🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2016-08-26
Trial ID
NCT02793856
Treatments Being Tested
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02867332
Treatments Being Tested
This study will evaluate the safety and effect of transcatheter arterial ch...
Status
Unknown
Location
The 3rd Xiangya Hospital of Central South University
Start Date
2019-06-20
Trial ID
NCT04417764
Treatments Being Tested
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Withdrawn
Location
Department of Urology Peking University First Hospital
Start Date
2016-11
Trial ID
NCT02867345
Treatments Being Tested
The study is to assess the safety and efficacy of the anti-MUC1 CAR T cells...
Status
Unknown
Location
First Affiliated Hospital of Guangdong Pharmaceutical University
Start Date
2018-02-01
Trial ID
NCT03525782
Treatments Being Tested
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Withdrawn
Location
Department of Urology Peking University First Hospital
Start Date
2016-09
Trial ID
NCT02863913
Treatments Being Tested
The goal of this Phase I/II observational and interventional platform study...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07307053
The study is to assess the safety and efficacy of the immunotherapies using...
Status
Unknown
Location
First Affiliated Hospital of Guangdong Pharmaceutical University
Start Date
2018-09-28
Trial ID
NCT03706326
T-cell exhaustion may limit long-term immunity in COVID-19 patients. T cell...
Status
Unknown
Location
Multiple Locations
Start Date
2021-08
Trial ID
NCT04990557
Treatments Being Tested
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Completed
Location
Hangzhou Cancer Hospital
Start Date
2017-03-14
Trial ID
NCT03081715
Treatments Being Tested